<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04144803</url>
  </required_header>
  <id_info>
    <org_study_id>BOPRA</org_study_id>
    <nct_id>NCT04144803</nct_id>
  </id_info>
  <brief_title>Brain Oxygenation During Prehospital Anesthesia: an Observational Study</brief_title>
  <acronym>BOPRA</acronym>
  <official_title>Brain Oxygenation During Prehospital Anesthesia: an Observational Study (The BOPRA Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>FinnHEMS Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lapland Hospital District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Metropolia University of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tampere University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Savonia University of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brain oxygenation of adult patients undergoing prehospital emergency anesthesia is monitored
      using noninvasive near-infrared spectroscopy. Patients are afterwards interviewed to define
      neurological outcome to measure quality of life. The purpose of this study is to reveal the
      risk factors of prehospital anesthesia related cerebral desaturation events (CDE) and to
      define the association between CDE and survival, neurological outcome or quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 18, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Favorable neurological outcome</measure>
    <time_frame>30 days</time_frame>
    <description>modified Rankin scale ≤2 (scale 0-6, 0 asymptomatic, 6 expired)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral desaturation event</measure>
    <time_frame>through prehospital care, approximately 60 minutes</time_frame>
    <description>an absolute drop of forehead cerebral saturation ≥ 10% from baseline for ≥ 5 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>30 days</time_frame>
    <description>Survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>365 days</time_frame>
    <description>Survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Favorable neurological outcome</measure>
    <time_frame>1 year</time_frame>
    <description>modified Rankin scale ≤2 (scale 0-6, 0 asymptomatic, 6 expired)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>15D score</measure>
    <time_frame>1 year</time_frame>
    <description>Heal-Related Quality of Life measured using 15-D instrument, scale 0-1 (0 = being dead, 0.0162 = being unconscious or comatose, 1 = no problems on any dimension = 'full' HRQOL)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Critically Ill</condition>
  <condition>Major Trauma</condition>
  <condition>Anesthesia</condition>
  <condition>Emergencies</condition>
  <arm_group>
    <arm_group_label>Cerebral desaturation group</arm_group_label>
    <description>absolute drop of forehead cerebral oxygen saturation ≥ 10% from baseline for ≥ 5 minutes during prehospital anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>no absolute drop of forehead cerebral oxygen saturation ≥ 10% from baseline for ≥ 5 minutes during prehospital anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cerebral near-infrared spectroscopy</intervention_name>
    <description>Nonin H500 one-channel near-infrared spectroscopy monitor on forehead of the patient from before induction of anesthesia to arrival to hospital</description>
    <arm_group_label>Cerebral desaturation group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing prehospital anesthesia and endotracheal intubation regardless of
        indication
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sedation or anesthesia provided to facilitate endotracheal intubation, performed by
             Helicopter Emergency Medical Services (HEMS) team regardless of the reason

        Exclusion Criteria:

          -  Ongoing cardiopulmonary resuscitation at the time of intubation

          -  Physical barrier for near-infrared spectroscopy measuring (e.g. forehead laceration)

          -  HEMS unit does not escort patient to the hospital (exception: in case of death on
             scene after inclusion, patient is included)

          -  Workload too high to ensure standard level of clinical care during the study

          -  For interviews: no competence in Finnish, Swedish or English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jouni Nurmi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jouni Nurmi, MD, PhD</last_name>
    <phone>+358 50 595 1576</phone>
    <email>jouni.nurmi@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Olkinuora, PhD</last_name>
    <phone>+358 400 237 211</phone>
    <email>anna.olkinuora@finnhems.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>FinnHEMS 60 / Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela Hiltunen, MD, PhD</last_name>
      <phone>+358 50 050 1023</phone>
      <email>pamela.hiltunen@kuh.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FinnHEMS 50 / Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lasse Raatiniemi, MD, PhD</last_name>
      <phone>+358 50 300 5575</phone>
      <email>lasse.raatiniemi@ppshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FinnHEMS 51 / Lapland hospital district</name>
      <address>
        <city>Rovaniemi</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simo Tukia, RN</last_name>
      <phone>+358 44 028 8841</phone>
      <email>simo.tukia@lshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FinnHEMS 30 / Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heini Piiroinen, MD</last_name>
      <phone>+358 44 522 1869</phone>
      <email>heini.piiroinen@pshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FinnHEMS 20 / Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miretta Tommila, MD, PhD</last_name>
      <phone>+358 50 590 6183</phone>
      <email>miretta.tommila@tyks.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FinnHEMS 10 / Helsinki University Hospital</name>
      <address>
        <city>Vantaa</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hetti Kirves, MD, PhD</last_name>
      <phone>+358 50 427 1790</phone>
      <email>hetti.kirves@hus.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 7, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>December 19, 2019</last_update_submitted>
  <last_update_submitted_qc>December 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Jouni Nurmi, MD</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

